EPHA2 and cardiovascular disorder: Reduced progression to advanced atherosclerotic plaques in EphA2(−/−)ApoE(−/−) mice suggests that EphA2 has an essential function in the early stage of cardiovascular disease (Neill et al., 2016; Cui et al., 2019).